Advice
Following an abbreviated submission
amlodipine/valsartan (Exforge) is accepted for use in NHS Scotland for patients whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.
In patients for whom concomitant use of these medicines as a fixed dose combination is appropriate it allows administration of a single tablet at no greater cost than valsartan (Diovan®) alone.
Angiotensin receptor blockers are an alternative to ACE inhibitors where these are not tolerated. This fixed dose combination is one of many options for the treatment of hypertension, many of which are less expensive.
Download detailed advice22KB (PDF)
Medicine details
- Medicine name:
- amlodipine besylate/valsartan (Exforge®)
- SMC ID:
- 350/07
- Indication:
- For patients whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.
- Pharmaceutical company
- Novartis Pharmaceuticals UK Ltd
- BNF chapter
- Cardiovascular system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 12 March 2007